Author:
Arsenijevic Milos,Milovanovic Marija,Jovanovic Snezana,Arsenijevic Natalija,Markovic Bojana Simovic,Gazdic Marina,Volarevic Vladislav
Publisher
Springer Science and Business Media LLC
Subject
Inorganic Chemistry,Biochemistry
Reference45 articles.
1. Abu-Surrah AS, Kettunen M (2006) Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin. Curr Med Chem 13:1337–1357
2. Kozubík A, Vaculová A, Soucek K, Vondrácek J, Turánek J, Hofmanová J (2008) Novel anticancer platinum(IV) complexes with adamantylamine: their efficiency and innovative chemotherapy strategies modifying lipid metabolism. Met Based Drugs 2008:417897
3. Florea AM, Büsselberg D (2011) Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel) 3:1351–1371
4. Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G (2012) Molecular mechanisms of cisplatin resistance. Oncogene 31:1869–1883
5. Boulikas T (2007) Molecular mechanisms of cisplatin and its liposomally encapsulated form, Lipoplatin™. Lipoplatin™ as a chemotherapy and antiangiogenesis drug. Cancer Therapy 5:351–376
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献